RWA
GILD icon

River Wealth Advisors’s Gilead Sciences GILD Stock Holding History

River Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-148
Closed -$9K – 278
2018
Q4 		$9K Sell
148
-411
-74% -$28.7K ﹤0.01% 424
2018
Q3 		$43K Sell
559
-496
-47% -$37.5K 0.02% 291
2018
Q2 		$75K Buy
+1,055
New +$74.5K 0.03% 230

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

River Wealth Advisors's GILD Position: Q1 2019 in Review

River Wealth Advisors sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 148 shares — an estimated $9K sold.

River Wealth Advisors first reported a position in GILD in Q2 2018 and held it in 3 quarters. The position peaked at $75K in Q2 2018. 1,491 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

  • River Wealth Advisors reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
  • River Wealth Advisors sold 148 Gilead Sciences shares in Q1 2019, an estimated $9K.
  • River Wealth Advisors first reported a position in Gilead Sciences in Q2 2018 and held it in 3 quarters.
  • River Wealth Advisors's Gilead Sciences position peaked at $75K in Q2 2018.
  • 1,491 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on River Wealth Advisors's 13F filing for Q1 2019, filed 7 May 2019.